Furthermore, HP1a-mediated heterochromatin formation reduces tumor progression by inhibiting Yki nuclear accumulation and activating the apoptotic pathway, likely via upregulating Rpr and Wts, two apoptotic genes. The gene discussed is LATS1; the disease is neoplasm.